Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography

Gene Therapy
P WilsD Scherman

Abstract

Plasmid DNA used for nonviral therapeutic gene transfer or nucleic acid vaccination has to be highly purified devoid of contaminating components such as bacterial proteins, endotoxins, or bacterial chromosomal DNA. We have developed a new affinity chromatography technique for plasmid DNA purification: triple-helix affinity chromatography (THAC). This technique is based on the sequence-specific interaction of an oligonucleotide forming a triple-helix with plasmid DNA. The oligonucleotide was covalently linked to a chromatographic matrix, thus providing a reusable affinity support. By inserting a suitable homopurine sequence in the plasmid DNA, it is possible to obtain a triple-helix interaction that will only be stable at mild acidic pH and that will dissociate in alkaline conditions. A crude lysate from a recombinant E. coli, or a pre-purified plasmid DNA, is thus applied at acidic pH on to a THAC column. After extensive washing of the column, purified plasmid DNA is eluted using an alkaline buffer. The binding conditions of the plasmid DNA on to the column have been optimized, as well as the hybridization sequence and the linker group between the matrix and the third strand oligonucleotide. The THAC technique makes it possible...Continue Reading

Citations

Jul 13, 2002·Biotechnology and Bioengineering·Jürgen J Hubbuch, Owen R T Thomas
Jul 13, 2002·Biotechnology and Bioengineering·John WoodgateNigel K H Slater
Sep 1, 2001·The Journal of Gene Medicine·M Faria, C Giovannangeli
Apr 27, 2007·Analytical and Bioanalytical Chemistry·Kamakshaiah Charyulu DevarayapalliKeisuke Makino
Jun 7, 2011·Analytical and Bioanalytical Chemistry·Seung Pil PackKeisuke Makino
Dec 26, 2012·Analytica Chimica Acta·Ashraf GhanemFrady G Adly
Apr 15, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Alex Eon-Duval, Gemma Burke
Jun 26, 1998·Journal of Chromatography. a·D M PrazeresC Cooney
Jun 17, 2000·Trends in Biotechnology·M S LevyP Dunnill
Aug 16, 2000·Trends in Biotechnology·G N FerreiraJ M Cabral
Jun 5, 2007·Nature Protocols·U Loi LaoWilfred Chen
Jun 17, 2006·Chemical Communications : Chem Comm·Jayden A Smith, F Richard Keene
Sep 24, 2005·Journal of Molecular Microbiology and Biotechnology·Wolfgang JechlingerPeter Mayrhofer
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·M FariaC Giovannangeli
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·C EscudéC Hélène
Jun 9, 2015·Molecular Therapy. Methods & Clinical Development·Xiaohu H HouZhi-Ying Chen
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·F SousaJ A Queiroz
Jan 23, 1999·Journal of Chromatography. a·P R LevisonV Grimm
Oct 14, 2014·Expert Review of Vaccines·Alex Xenopoulos, Priyabrata Pattnaik
Dec 23, 2006·Expert Review of Vaccines·Wolfgang Jechlinger
Aug 7, 2009·Trends in Biotechnology·Pedro H OliveiraGabriel A Monteiro
May 12, 2009·Journal of Biotechnology·Christina ParilAlois Jungbauer
Aug 5, 2008·Trends in Biotechnology·Fani SousaJoão A Queiroz
Sep 4, 2008·The Journal of Gene Medicine·Peter MayrhoferWolfgang Jechlinger
Jul 19, 2002·Biophysical Journal·Svetlana S ZakharovaJohan R C van der Maarel
Oct 15, 2014·ACS Applied Materials & Interfaces·Taraka Sai Pavan GrandhiKaushal Rege
Oct 21, 2003·Nucleosides, Nucleotides & Nucleic Acids·Jian-Sheng Sun, Claude Hélène
Dec 1, 2004·Lab on a Chip·Birgitte RegenbergThomas Ahl
Dec 22, 2017·Tissue Engineering. Part B, Reviews·Ara Hacobian, David Hercher
Jan 30, 2004·Biotechnology and Bioengineering·Jan KostalWilfred Chen
Sep 8, 2004·Biotechnology and Bioengineering·P-O WahlundI Yu Galaev
Jan 7, 2003·Biotechnology and Bioengineering·Matteo D CostioliRuth Freitag
Apr 29, 2006·Biotechnology and Bioengineering·Gareth M FordeAnthony G Hitchcock
Aug 19, 2006·Biotechnology and Bioengineering·Saethawat Chamsart, Tanyawat Karnjanasorn
May 1, 2007·Biotechnology Journal·Peter TiainenPer-Olof Larsson
May 15, 2007·Biotechnology and Bioengineering·Richard A J DarbyAnna V Hine
Sep 17, 2010·Journal of Separation Science·Angela SousaJoão A Queiroz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.